Each AK gene is deregulated in one or more types of human cancer, and further studies identifying residues that experienced purifying or diversifying selective pressure may aid in the combined bioinformatic and cheminformatic design of pan or isoform-specific aurora kinase inhibitors, respectively. This evidence concerns the gene ADK and cancer.